title: Management of amyotrophic lateral sclerosis with riluzole.
abstract: In summary, riluzole is a recently-released drug for the treatment of ALS. While it will not cure the disease, it does prolong survival time and ventilator-free time. Riluzole has few adverse effects, but liver enzymes should be watched closely for elevations.
authors.affiliation: Baylor University School of Nursing, Dallas, Texas 75243, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Neatherlin
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000451:nursing; D006801:Humans; D007255:Information Services; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018579:Patient Selection; D019782:Riluzole / Q000494:pharmacology / Q000627:therapeutic use*; D012657:Self-Help Groups
chemical_list: D018696:Neuroprotective Agents; D019782:Riluzole